 Vishal Rana
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2025 | 1958 | 0.260 |
Why?
| | Hodgkin Disease | 1 | 2025 | 171 | 0.190 |
Why?
| | Carcinoma, Renal Cell | 1 | 2023 | 234 | 0.160 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 412 | 0.140 |
Why?
| | Mechlorethamine | 1 | 2013 | 53 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2019 | 683 | 0.090 |
Why?
| | Lymphoma | 1 | 2013 | 233 | 0.090 |
Why?
| | Adenocarcinoma | 3 | 2008 | 931 | 0.090 |
Why?
| | Liver Diseases | 1 | 2013 | 304 | 0.080 |
Why?
| | Dacarbazine | 2 | 2025 | 100 | 0.080 |
Why?
| | Pancreatic Neoplasms | 2 | 2007 | 927 | 0.070 |
Why?
| | Intracranial Hemorrhages | 1 | 2009 | 100 | 0.070 |
Why?
| | Radiotherapy, High-Energy | 1 | 2008 | 18 | 0.070 |
Why?
| | Aged, 80 and over | 8 | 2019 | 8279 | 0.070 |
Why?
| | Doxorubicin | 2 | 2025 | 397 | 0.070 |
Why?
| | Nose Neoplasms | 1 | 2007 | 21 | 0.070 |
Why?
| | Common Bile Duct Neoplasms | 1 | 2007 | 27 | 0.070 |
Why?
| | Ampulla of Vater | 1 | 2007 | 39 | 0.060 |
Why?
| | POEMS Syndrome | 1 | 2006 | 3 | 0.060 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2006 | 35 | 0.060 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 128 | 0.060 |
Why?
| | Carcinoma | 1 | 2007 | 228 | 0.060 |
Why?
| | Neoplasm Staging | 2 | 2025 | 1465 | 0.050 |
Why?
| | Aged | 9 | 2025 | 25947 | 0.050 |
Why?
| | Remission Induction | 2 | 2019 | 308 | 0.050 |
Why?
| | Middle Aged | 10 | 2025 | 35928 | 0.050 |
Why?
| | Capecitabine | 3 | 2007 | 57 | 0.050 |
Why?
| | Radiotherapy Dosage | 3 | 2008 | 289 | 0.050 |
Why?
| | Prognosis | 4 | 2019 | 4293 | 0.050 |
Why?
| | Anilides | 1 | 2023 | 84 | 0.050 |
Why?
| | Fluorouracil | 3 | 2007 | 235 | 0.040 |
Why?
| | Deoxycytidine | 3 | 2007 | 221 | 0.040 |
Why?
| | Combined Modality Therapy | 3 | 2008 | 1268 | 0.040 |
Why?
| | Treatment Outcome | 5 | 2019 | 11695 | 0.040 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 1182 | 0.040 |
Why?
| | Stroke | 1 | 2009 | 1258 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2009 | 1322 | 0.040 |
Why?
| | Palliative Care | 1 | 2008 | 1008 | 0.040 |
Why?
| | Neoplasm, Residual | 1 | 2019 | 139 | 0.040 |
Why?
| | Pyridines | 1 | 2023 | 605 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2019 | 5417 | 0.040 |
Why?
| | Azacitidine | 1 | 2019 | 157 | 0.030 |
Why?
| | Male | 10 | 2025 | 72406 | 0.030 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 280 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 2 | 2008 | 222 | 0.030 |
Why?
| | Adult | 7 | 2025 | 40506 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2023 | 988 | 0.030 |
Why?
| | Genetic Testing | 1 | 2019 | 482 | 0.030 |
Why?
| | Female | 9 | 2025 | 78376 | 0.030 |
Why?
| | Sulfonamides | 1 | 2019 | 581 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2009 | 2642 | 0.030 |
Why?
| | Humans | 11 | 2025 | 144957 | 0.030 |
Why?
| | Survival Analysis | 2 | 2009 | 1385 | 0.030 |
Why?
| | Vinblastine | 1 | 2013 | 75 | 0.030 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 97 | 0.020 |
Why?
| | Bilirubin | 1 | 2013 | 97 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2013 | 266 | 0.020 |
Why?
| | Vincristine | 1 | 2013 | 140 | 0.020 |
Why?
| | Prednisone | 1 | 2013 | 221 | 0.020 |
Why?
| | Rituximab | 1 | 2013 | 210 | 0.020 |
Why?
| | Bleomycin | 1 | 2013 | 253 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2013 | 343 | 0.020 |
Why?
| | Retrospective Studies | 4 | 2009 | 17101 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 333 | 0.020 |
Why?
| | Jejunostomy | 1 | 2008 | 13 | 0.020 |
Why?
| | Probability | 1 | 2009 | 312 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 403 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 386 | 0.020 |
Why?
| | Carcinoma, Adenoid Cystic | 1 | 2007 | 19 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14126 | 0.020 |
Why?
| | Nasal Septum | 1 | 2007 | 30 | 0.020 |
Why?
| | Nasal Cavity | 1 | 2007 | 62 | 0.020 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2008 | 58 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 798 | 0.020 |
Why?
| | Pancreaticoduodenectomy | 1 | 2007 | 135 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2007 | 421 | 0.010 |
Why?
| | Gastrostomy | 1 | 2008 | 130 | 0.010 |
Why?
| | Deglutition Disorders | 1 | 2008 | 147 | 0.010 |
Why?
| | Gastrectomy | 1 | 2008 | 161 | 0.010 |
Why?
| | Radiation Dosage | 1 | 2007 | 193 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2006 | 292 | 0.010 |
Why?
| | Adolescent | 1 | 2025 | 22453 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 2006 | 769 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1311 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2738 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1540 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 2092 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2007 | 642 | 0.010 |
Why?
| | Pain | 1 | 2008 | 782 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2883 | 0.010 |
Why?
| | Disease Progression | 1 | 2008 | 2852 | 0.010 |
Why?
| | Registries | 1 | 2009 | 2385 | 0.010 |
Why?
| | Risk Assessment | 1 | 2009 | 3676 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7183 | 0.010 |
Why?
| | Cohort Studies | 1 | 2006 | 5965 | 0.010 |
Why?
|
|
Rana's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|